199 related articles for article (PubMed ID: 34076341)
1. National variation in the delivery of radiation oncology procedures in the non-facility-based setting.
Valle LF; Chu FI; Kundu P; Yoon SM; Gilchrist T; Steinberg ML; Raldow AC
Cancer Med; 2021 Jul; 10(14):4734-4742. PubMed ID: 34076341
[TBL] [Abstract][Full Text] [Related]
2. Provider-Level Variation in Treatment Planning of Radiation Oncology Procedures in the United States.
Valle LF; Chu FI; Yoon SM; Kundu P; Venkat P; Gilchrist T; Steinberg ML; Raldow AC
JCO Oncol Pract; 2021 Dec; 17(12):e1905-e1912. PubMed ID: 33417480
[TBL] [Abstract][Full Text] [Related]
3. Provider variability in intensity modulated radiation therapy utilization among Medicare beneficiaries in the United States.
Grant SR; Smith BD; Likhacheva AO; Shirvani SM; Rosen DB; Guadagnolo BA; Shumway DA; Holliday EB; Chamberlain D; Walker GV
Pract Radiat Oncol; 2018; 8(5):e329-e336. PubMed ID: 29861349
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Differences in Clinical Activity and Medicare Payments Among Female and Male Radiation Oncologists.
Valle L; Weng J; Jagsi R; Chu FI; Ahmad S; Steinberg M; Raldow A
JAMA Netw Open; 2019 Mar; 2(3):e190932. PubMed ID: 30901047
[TBL] [Abstract][Full Text] [Related]
5. Influence of Geography on Prostate Cancer Treatment.
Tang C; Lei X; Smith GL; Pan HY; Hoffman KE; Kumar R; Chapin BF; Shih YT; Frank SJ; Smith BD
Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1286-1295. PubMed ID: 33316361
[TBL] [Abstract][Full Text] [Related]
6. Variations in Medicare Reimbursement in Radiation Oncology: An Analysis of the Medicare Provider Utilization and Payment Data Set.
Vu CC; Lanni TB; Robertson JM
Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1000-5. PubMed ID: 27026306
[TBL] [Abstract][Full Text] [Related]
7. Opioid prescription patterns among radiation oncologists in the United States.
Huang TQ; Chang EM; Grogan TR; Martin EJ; Raldow AC
Cancer Med; 2020 May; 9(10):3297-3304. PubMed ID: 32167661
[TBL] [Abstract][Full Text] [Related]
8. [Status report of Hungarian radiotherapy based on treatment data, available infrastucture, and human resources].
Polgár C; Major T; Király R; Fodor J; Kásler M
Magy Onkol; 2015 Jun; 59(2):85-94. PubMed ID: 26035155
[TBL] [Abstract][Full Text] [Related]
9. Time-driven activity-based cost comparison of prostate cancer brachytherapy and intensity-modulated radiation therapy.
Dutta SW; Bauer-Nilsen K; Sanders JC; Trifiletti DM; Libby B; Lash DH; Lain M; Christodoulou D; Hodge C; Showalter TN
Brachytherapy; 2018; 17(3):556-563. PubMed ID: 29519605
[TBL] [Abstract][Full Text] [Related]
10. The Impact of Radiation Oncologists on the Early Adoption of Hypofractionated Radiation Therapy for Early-Stage Breast Cancer.
Boero IJ; Gillespie EF; Hou J; Paravati AJ; Kim E; Einck JP; Yashar C; Mell LK; Murphy JD
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):571-580. PubMed ID: 28126306
[TBL] [Abstract][Full Text] [Related]
11. Geographic access to brachytherapy services in the United States.
Bates JE; Thaker NG; Parekh A; Royce TJ
Brachytherapy; 2022; 21(1):29-32. PubMed ID: 34148829
[TBL] [Abstract][Full Text] [Related]
12. Patterns of radiotherapy practice for patients with squamous carcinoma of the uterine cervix: patterns of care study.
Eifel PJ; Moughan J; Owen J; Katz A; Mahon I; Hanks GE
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):351-8. PubMed ID: 10030261
[TBL] [Abstract][Full Text] [Related]
13. The early adoption of intensity-modulated radiotherapy and stereotactic body radiation treatment among older Medicare beneficiaries with prostate cancer.
Jacobs BL; Yabes JG; Lopa SH; Heron DE; Chang CH; Schroeck FR; Bekelman JE; Kahn JM; Nelson JB; Barnato AE
Cancer; 2017 Aug; 123(15):2945-2954. PubMed ID: 28301689
[TBL] [Abstract][Full Text] [Related]
14. The adoption of new adjuvant radiation therapy modalities among Medicare beneficiaries with breast cancer: clinical correlates and cost implications.
Roberts KB; Soulos PR; Herrin J; Yu JB; Long JB; Dostaler E; Gross CP
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1186-92. PubMed ID: 23182396
[TBL] [Abstract][Full Text] [Related]
15. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study.
Erickson B; Eifel P; Moughan J; Rownd J; Iarocci T; Owen J
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1083-92. PubMed ID: 16099599
[TBL] [Abstract][Full Text] [Related]
16. Utilization of Intensity-Modulated Radiation Therapy for Malignant Pleural Mesothelioma in the United States.
Shaaban SG; Verma V; Choi JI; Shabason J; Sharma S; Glass E; Grover S; Badiyan SN; Simone CB
Clin Lung Cancer; 2018 Sep; 19(5):e685-e692. PubMed ID: 29803576
[TBL] [Abstract][Full Text] [Related]
17. Implications of Radiotherapy Utilization in Korea from 2010 to 2019.
Lee J; Kim WC; Yoon WS; Rim CH
J Korean Med Sci; 2021 May; 36(18):e117. PubMed ID: 33975394
[TBL] [Abstract][Full Text] [Related]
18. The Influence of Health Insurance Policy on Radiation Oncology Physician SBRT/SABR Use Practices: A North American Survey.
Guo J; Kim H; Kalchman I; Dan TD; Zhan T; Werner-Wasik M
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):524-529. PubMed ID: 29280445
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic Body Radiation Therapy, Intensity-Modulated Radiation Therapy, and Brachytherapy Boost Modalities in Invasive Cervical Cancer: A Study of the National Cancer Data Base.
OʼDonnell B; Shiao JC; Pezzi TA; Waheed N; Sharma S; Bonnen MD; Ludwig MS
Int J Gynecol Cancer; 2018 Mar; 28(3):563-574. PubMed ID: 29324547
[TBL] [Abstract][Full Text] [Related]
20. Prostate-specific antigen kinetics and biochemical control following stereotactic body radiation therapy, high dose rate brachytherapy, and low dose rate brachytherapy: A multi-institutional analysis of 3502 patients.
Levin-Epstein R; Cook RR; Wong JK; Stock RG; Jeffrey Demanes D; Collins SP; Aghdam N; Suy S; Mantz C; Katz AJ; Nickols NG; Miszczyk L; Napieralska A; Namysl-Kaletka A; Prionas ND; Bagshaw H; Buyyounouski MK; Cao M; Mahal BA; Shabsovich D; Dang A; Yuan Y; Rettig MB; Chang AJ; Jackson WC; Spratt DE; Lehrer EJ; Zaorsky NG; Kupelian PA; Steinberg ML; Horwitz EM; Jiang NY; Kishan AU
Radiother Oncol; 2020 Oct; 151():26-32. PubMed ID: 32663537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
